Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy Optimization.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Comparison of rectal and bladder dose between retractor insertion and gauze packing in intracavitary brachytherapy for cervical cancer.

Journal of radiation research·2025
Same author

A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

Long-term follow-up of chronic osteomyelitis after bone tumor resection.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2024
Same author

Risk Factors and Impact on Survival of Pathological Fractures in Patients With Humeral Metastasis.

Cureus·2024
Same author

Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2024

Related Experiment Video

Updated: Jul 9, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Brachytherapy with permanent seed implantation.

Shiro Saito1, Hirohiko Nagata, Michio Kosugi

  • 1Department of Urology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan. ssaito@ntmc.hosp.go.jp

International Journal of Clinical Oncology
|December 12, 2007
PubMed
Summary

Permanent seed brachytherapy for prostate cancer, using iodine-125 seeds, is now approved in Japan. This effective, minimally invasive treatment offers low morbidity and is becoming more common following strict guidelines and training.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Experiment Videos

Last Updated: Jul 9, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Permanent interstitial brachytherapy with iodine-125 (I-125) or palladium-103 (Pd-103) seeds is a widely adopted treatment for localized prostate cancer in the United States, often replacing radical prostatectomy due to high efficacy and low morbidity.
  • Japan's strict radiation safety laws previously prevented the use of permanent seed implantation, despite its established benefits.
  • Following extensive discussions, permanent interstitial brachytherapy with I-125 was approved in Japan in July 2003, with specific institutional guidelines.

Purpose of the Study:

  • To report the approval and initial implementation of permanent interstitial brachytherapy with iodine-125 (I-125) for prostate cancer in Japan.
  • To highlight the efforts undertaken to ensure quality, safety, and improved clinical outcomes for this new treatment modality in Japan.
  • To project the increasing adoption and impact of brachytherapy for prostate cancer in Japan.

Main Methods:

  • The study describes the regulatory approval process and the subsequent implementation of I-125 brachytherapy in Japan.
  • It mentions the establishment of guidelines and restrictions for participating institutions.
  • Ongoing quality improvement initiatives include medical conferences, technical training, and multi-institutional clinical studies.

Main Results:

  • Permanent interstitial brachytherapy with I-125 was approved in Japan in July 2003.
  • Over 70 institutions initiated the treatment by June 2007.
  • Quality assurance measures, including training and studies, are actively being conducted nationwide.

Conclusions:

  • Permanent interstitial brachytherapy with I-125 represents a significant advancement in prostate cancer treatment in Japan.
  • The treatment is expected to become more prevalent due to its efficacy, minimally invasive nature, and low morbidity.
  • Continuous quality improvement efforts are crucial for optimizing clinical outcomes and radiation safety.